InsidersTradesSigma
Discover the full management transaction log of 박셀바이오, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 박셀바이오 has logged 2 public disclosures. Market capitalisation: €145.1bn. The latest transaction was disclosed on 27 March 2026 — Purchase. Among the most active insiders: 이제중. The full history is openly available.
FY ended December 2025 · cache
0 of 0 declarations